Moderate Inflammatory, Autoimmune & Degenerative Myopathies

Transient Synovitis of the Hip

Acute Self-Limiting Joint Synovial Inflammation

Primary risk age: 3 to 8 Years (Most common cause of pediatric hip pain)

Urgency: Moderate
Typical age: 3 to 8 Years (Most common cause of pediatric hip pain)
Body system: Musculoskeletal System

Typical course: 1 to 2 weeks.

Reviewed against AAP · CDC · WHO · NHS guidance Last reviewed 2026-06-13

1. Summary & Pathophysiology

Acute Self-Limiting Joint Synovial Inflammation

Pathophysiology (Development Path)

Cross-reactive immune antibodies from a recent viral infection target the synovial lining of the hip joint. This causes acute synovial hypercellularity, inflammation, and fluid accumulation (effusion), increasing joint capsule pressure, causing pain, and limiting movement.

Primary Causes & Etiology

Immune-mediated transient inflammation within the joint space, highly associated with a recent viral upper respiratory or gastrointestinal infection.

2. Symptom Continuum

Early Onset Signs
Sudden onset of unilateral hip, groin, or thigh pain, causing the child to refuse weight-bearing or walk with a limp.
Progressive Phase
Referred pain down to the knee; limited range of motion of the hip, especially during abduction and internal rotation.
Severe Indicators
Low-grade fever (usually under 38°C); hip held in a flexed, abducted, and externally rotated position to minimize joint tension.

3. Clinical Verification

Exclusion of septic arthritis. Hip ultrasonography demonstrates joint effusion. Complete blood count and inflammatory markers (ESR, CRP) are normal or minimally elevated.

4. Care & Elements Plan

Primary Care Treatment Plan

Strict bed rest and restriction of all weight-bearing activity until pain resolves. Implement anti-inflammatory analgesics.

Home Support Elements

Keep child resting; apply warm compresses to the hip joint; assist with positional changes; closely monitor for fever or increasing pain.

Generic Active Ingredients (No Brands)

Ibuprofen (generic nonsteroidal anti-inflammatory drug active ingredient to suppress synovial inflammation and manage pain).

Lists active elements only. Never administer self-designed therapies.

5. Doctor Critical Lines

Critical Thresholds: When to See a Doctor

Seek immediate emergency evaluation if the child develops a high fever, severe pain, joint swelling, or if the limp fails to resolve within 10 days, to rule out Septic Arthritis.

6. Vaccine & Prevention

Routine Prophylaxis (Prevention)

No specific prevention; maintain standard hygiene practices to avoid primary viral infections.

Immunization Context

No immunization exists.

7. Timelines & Outlook

Active Timeline

1 to 2 weeks.

Expected Prognosis

Excellent; resolves completely within 1 to 2 weeks with zero long-term joint or bone sequelae.

Potential Untreated Complications

Recurrent synovitis (occurs in ~5-10% of cases); coxae magna (temporary femoral head enlargement, benign).

Moderate

Juvenile Idiopathic Arthritis (JIA)

Chronic Pediatric Autoimmune Inflammatory Arthritis

Toddlerhood through Adolescence (Onset before 16 years; varies by subtype)

Severe

Duchenne Muscular Dystrophy (DMD)

X-Linked Recessive Progressive Myopathic Degeneration

Toddlerhood through Young Adulthood (Symptoms present between 2 to 5 years; affects boys)